Lathrop Investment Management Corp Sells 3,177 Shares of CVS Health Co. (NYSE:CVS)

Lathrop Investment Management Corp lessened its position in shares of CVS Health Co. (NYSE:CVS) by 2.4% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 129,129 shares of the pharmacy operator’s stock after selling 3,177 shares during the period. CVS Health accounts for 2.1% of Lathrop Investment Management Corp’s holdings, making the stock its 27th biggest holding. Lathrop Investment Management Corp’s holdings in CVS Health were worth $10,196,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the company. FMR LLC grew its holdings in shares of CVS Health by 29.1% during the third quarter. FMR LLC now owns 27,487,238 shares of the pharmacy operator’s stock valued at $1,919,159,000 after buying an additional 6,194,441 shares during the last quarter. International Assets Investment Management LLC grew its holdings in shares of CVS Health by 8,697.2% during the fourth quarter. International Assets Investment Management LLC now owns 1,322,129 shares of the pharmacy operator’s stock valued at $104,395,000 after buying an additional 1,307,100 shares during the last quarter. Canada Pension Plan Investment Board grew its holdings in shares of CVS Health by 49.9% during the third quarter. Canada Pension Plan Investment Board now owns 2,095,978 shares of the pharmacy operator’s stock valued at $146,341,000 after buying an additional 698,054 shares during the last quarter. Pacer Advisors Inc. grew its holdings in shares of CVS Health by 12.6% during the fourth quarter. Pacer Advisors Inc. now owns 5,513,230 shares of the pharmacy operator’s stock valued at $435,325,000 after buying an additional 616,785 shares during the last quarter. Finally, J.P. Morgan Private Wealth Advisors LLC acquired a new position in shares of CVS Health during the third quarter valued at about $34,379,000. Institutional investors own 80.66% of the company’s stock.

Insiders Place Their Bets

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the business’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $76.95, for a total value of $2,267,947.35. Following the completion of the transaction, the executive vice president now owns 39,765 shares of the company’s stock, valued at approximately $3,059,916.75. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.24% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on CVS shares. StockNews.com cut shares of CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. Barclays began coverage on shares of CVS Health in a research report on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 price target on the stock. Leerink Partnrs reissued an “outperform” rating on shares of CVS Health in a research report on Monday, February 26th. Wells Fargo & Company dropped their price target on shares of CVS Health from $83.00 to $76.00 and set an “equal weight” rating on the stock in a research report on Monday, April 8th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $87.00 price target on shares of CVS Health in a research report on Wednesday, April 10th. Four investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $89.44.

CVS Health Price Performance

NYSE:CVS traded down $0.15 during mid-day trading on Friday, hitting $67.18. 6,396,438 shares of the stock traded hands, compared to its average volume of 8,376,818. The business’s 50-day moving average price is $74.42 and its 200 day moving average price is $73.64. The company has a market cap of $84.68 billion, a PE ratio of 10.40, a price-to-earnings-growth ratio of 0.89 and a beta of 0.52. CVS Health Co. has a 12-month low of $64.41 and a 12-month high of $83.25. The company has a quick ratio of 0.63, a current ratio of 0.86 and a debt-to-equity ratio of 0.77.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, beating the consensus estimate of $2.01 by $0.11. The company had revenue of $93.81 billion during the quarter, compared to analysts’ expectations of $90.58 billion. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. CVS Health’s revenue for the quarter was up 11.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.99 earnings per share. On average, analysts expect that CVS Health Co. will post 8.31 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be paid a $0.665 dividend. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a yield of 3.96%. CVS Health’s dividend payout ratio is presently 41.18%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.